These results, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the idea of concentrating on ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Diseases. Opioid withdrawal is a https://conolidine-1-the-original23837.blog-a-story.com/6675567/conolidine-secrets